Compare RRX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RRX | BIO |
|---|---|---|
| Founded | 1955 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7B | 6.9B |
| IPO Year | 1994 | N/A |
| Metric | RRX | BIO |
|---|---|---|
| Price | $204.63 | $303.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $210.70 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 1.1M | 441.7K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | ★ 42.86 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $3,257,100,000.00 | N/A |
| Revenue This Year | $4.20 | $2.74 |
| Revenue Next Year | $12.13 | $3.20 |
| P/E Ratio | $217.81 | ★ $9.72 |
| Revenue Growth | ★ 5.21 | N/A |
| 52 Week Low | $127.96 | $211.43 |
| 52 Week High | $236.35 | $343.12 |
| Indicator | RRX | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 68.41 |
| Support Level | $198.98 | $293.88 |
| Resistance Level | $222.63 | $311.53 |
| Average True Range (ATR) | 9.32 | 9.32 |
| MACD | -0.53 | 5.84 |
| Stochastic Oscillator | 64.66 | 97.77 |
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.